Clinical Trial: A COMPARATIVE STUDY TO EVALUATE THE EFFICACY AND SAFETY OF IROCHEL (UNANI CODED FORMULATION) FOR THE MANAGEMENT OF HUMORAL IMBALANCE (SU'E AKHLAT) CAUSED BY TRANSFUSION INDUCED IRON OVERLOAD IN THALASSEMIA PATIENTS IN COMPARISON WITH DEFEROXAMINE (ALLOPATHIC MEDICINES)

U.S., Aug. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07782931) titled 'A COMPARATIVE STUDY TO EVALUATE THE EFFICACY AND SAFETY OF IROCHEL (UNANI CODED FORMULATION) FOR THE MANAGEMENT OF HUMORAL IMBALANCE (SU'E AKHLAT) CAUSED BY TRANSFUSION INDUCED IRON OVERLOAD IN THALASSEMIA PATIENTS IN COMPARISON WITH DEFEROXAMINE (ALLOPATHIC MEDICINES)' on Aug. 20.

Brief Summary: This research study was an experimental, randomized, controlled clinical trial to evaluate the safety and efficacy of coded Unani formulation Irochel for the management of IOL due to repetitive blood transfusion in comparison with DFO in already diagnosed 132 transfusion-dependent thalassemia patients of both genders of 10 years to 16 years...